Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase 1 26Phase 1/2 19Phase 3 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 103Unknown 63Recruiting 12Terminated 10Active not recruiting 8Suspended 2Enrolling by invitation 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 743INDUSTRY 48OTHER_GOV 9NETWORK 7FED 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 1Hodgkin Disease 1

Interventions

fludarabine phosphate 1Cyclophosphamide 1B3(Fv)-PE38KDEL recombinant immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × NIH × Clear all
NCT00389506 2012-03-16

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase NA Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡